Generic GLP-1 Is About To Come Out IN India, Projecting 12 Million Pens Sold In First Year
India is about to witness a significant shift as Dr Reddy’s Laboratories prepares to introduce a generic version of the blockbuster diabetes treatment to the market. According to sources, he company has received regulatory approval from India’s d**g regulator to manufacture and distribute the semaglutide-based treatment, marking a major milestone in making this sought-after medication … Read more